Related Experiment Video
Updated: May 4, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Current management of fecal incontinence
Jennifer Y Wang1, Maher A Abbas
1General and Colorectal Surgeon at the San Jose Medical Center in CA.
Objective:
To review the management of fecal incontinence, which affects more than 1 in 10 people and can have a substantial negative impact on quality of life.
Methods:
The medical literature between 1980 and April 2012 was reviewed for the evaluation and management of fecal incontinence.
Results:
A comprehensive history and physical examination are required to help understand the severity and type of symptoms and the cause of incontinence. Treatment options range from medical therapy and minimally invasive interventions to more invasive procedures with varying degrees of morbidity. The treatment approach must be tailored to each patient. Many patients can have substantial improvement in symptoms with dietary management and biofeedback therapy. For younger patients with large sphincter defects, sphincter repair can be helpful. For patients in whom biofeedback has failed, other options include injectable medications, radiofrequency ablation, or sacral nerve stimulation. Patients with postdefecation fecal incontinence and a rectocele can benefit from rectocele repair. An artificial bowel sphincter is reserved for patients with more severe fecal incontinence.
Conclusion:
The treatment algorithm for fecal incontinence will continue to evolve as additional data become available on newer technologies.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS
Urinary Tract Infection IV: Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Urinary Tract Calculi III: Medical Management